文献速递流行病学与生物统计

比值比并非普遍可移植:对Doi等人观点的回应与效应变异模型呼吁

Controversy and Debate : Questionable utility of the relative risk in clinical research: Paper 4 :Odds Ratios are far from "portable" - A call to use realistic models for effect variation in meta-analysis.
PubMed 文献 · J Clin Epidemiol · 2021-08-11

本文回应Doi等人关于用比值比替代风险比的提议,基于Cochrane系统评价数据库中20,198项荟萃分析,实证比较比值比与风险比同基线风险的相关性。作者指出Doi等人的推理存在循环论证、转换方法偏倚等问题,结论认为比值比与风险比均非普遍可移植,应报告基于基线风险等效应修饰因素的效应变异。

要点

  • 比值比与风险比的可移植性均因场景而异,不存在普遍可移植的效应量。
  • Doi等人主张比值比可移植的推理存在循环论证与数学/实证结果混淆。
  • 荟萃分析与临床指南应报告以基线风险等为条件的效应变异。

核心结论

  • 用比值比替代风险比的建议基于循环论证,且混淆数学与实证结果,对荟萃分析和临床指导尤其误导。
  • 比值比与风险比均非普遍可移植,应报告以基线风险等效应修饰因素为条件的效应变异。

研究设计与样本

  • 本文为对Doi等人观点的回应性评论,利用Cochrane系统评价数据库中20,198项荟萃分析,进一步检验比值比与风险比同基线风险的相关性。

主要发现

  • Doi等人主张比值比可移植的推理是循环论证:假设比值比恒定的模型并在此模型下展示其可移植性。
  • Doi等人倡导的比值比转风险比方法存在偏倚。
  • Doi等人的实证例子可被反例反驳:存在风险比可移植而比值比不可移植的荟萃分析。
  • Doi等人误将荟萃分析中比值比随基线风险变异归因于碰撞偏倚(collider bias)。
  • 实证比较显示比值比与风险比同基线风险的相关性及可移植性因场景而异。

临床怎么用

  • 在荟萃分析与临床指导中,不应假设比值比或风险比普遍可移植。
  • 应报告以基线风险等效应修饰因素为条件的效应变异,以支持以患者为中心的实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recently Doi et al. argued that risk ratios should be replaced with odds ratios in clinical research. We disagreed, and empirically documented the lack of portability of odds ratios, while Doi et al. defended their position. In this response we highlight important errors in their position. STUDY DESIGN AND SETTING: We counter Doi et al.'s arguments by further examining the correlations of odds ratios, and risk ratios, with baseline risks in 20,198 meta-analyses from the Cochrane Database of Systematic Reviews. RESULTS: Doi et al.'s claim that odds ratios are portable is invalid because 1) their reasoning is circular: they assume a model under which the odds ratio is constant and show that under such a model the odds ratio is portable; 2) the method they advocate to convert odds ratios to risk ratios is biased; 3) their empirical example is readily-refuted by counter-examples of meta-analyses in which the risk ratio is portable but the odds ratio isn't; and 4) they fail to consider the causal determinants of meta-analytic inclusion criteria: Doi et al. mistakenly claim that variation in odds ratios with different baseline risks in meta-analyses is due to collider bias. Empirical comparison between the correlations of odds ratios, and risk ratios, with baseline risks show that the portability of odds ratios and risk ratios varies across settings. CONCLUSION: The suggestion to replace risk ratios with odds ratios is based on circular reasoning and a confusion of mathematical and empirical results. It is especially misleading for meta-analyses and clinical guidance. Neither the odds ratio nor the risk ratio is universally portable. To address this lack of portability, we reinforce our suggestion to report variation in effect measures conditioning on modifying factors such as baseline risk; understanding such variation is essential to patient-centered practice.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Xiao M, Chu H, Cole SR, et al. Controversy and Debate : Questionable utility of the relative risk in clinical research: Paper 4 :Odds Ratios are far from "portable" - A call to use realistic models for effect variation in meta-analysis. J Clin Epidemiol. 2021. PMID: 34390790. doi:10.1016/j.jclinepi.2021.08.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。